Sara Salerno

1.3k total citations · 1 hit paper
19 papers, 948 citations indexed

About

Sara Salerno is a scholar working on Hematology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sara Salerno has authored 19 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Pharmacology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Sara Salerno's work include Chronic Myeloid Leukemia Treatments (8 papers), Acute Myeloid Leukemia Research (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Sara Salerno is often cited by papers focused on Chronic Myeloid Leukemia Treatments (8 papers), Acute Myeloid Leukemia Research (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Sara Salerno collaborates with scholars based in United States, Canada and South Africa. Sara Salerno's co-authors include Neil P. Shah, Lauren E. Damon, Catherine C. Smith, Patrick P. Zarrinkar, Jeremy P. Hunt, Alexander E. Perl, Mark J. Levis, Andrew Kasarskis, Kevin Travers and Susana Wang and has published in prestigious journals such as Nature, Blood and Cancer Research.

In The Last Decade

Sara Salerno

19 papers receiving 929 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia

2012 542 citations Catherine C. Smith, Qi Wang et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Salerno United States	10	586	397	272	89	84	19	948
Jesús Martín Spain	15	426 0.7×	254 0.6×	68 0.3×	57 0.6×	148 1.8×	41	939
Thomas Emm United States	11	219 0.4×	158 0.4×	254 0.9×	40 0.4×	157 1.9×	16	694
Leslie A. Kenna United States	9	166 0.3×	169 0.4×	116 0.4×	72 0.8×	119 1.4×	9	640
Cecil Ross India	16	327 0.6×	179 0.5×	245 0.9×	57 0.6×	49 0.6×	51	781
Janel Long-Boyle United States	15	283 0.5×	91 0.2×	83 0.3×	120 1.3×	101 1.2×	43	578
Marta Spreafico Italy	19	405 0.7×	157 0.4×	122 0.4×	33 0.4×	56 0.7×	38	976
R E Clark United Kingdom	15	466 0.8×	145 0.4×	304 1.1×	102 1.1×	282 3.4×	24	821
Marius Dohse Germany	9	180 0.3×	230 0.6×	128 0.5×	157 1.8×	497 5.9×	13	788
Amina Haouala Switzerland	11	272 0.5×	146 0.4×	195 0.7×	14 0.2×	145 1.7×	18	591
Yow‐Ming Wang United States	18	179 0.3×	350 0.9×	115 0.4×	120 1.3×	226 2.7×	54	1.0k

Countries citing papers authored by Sara Salerno

Since Specialization

Citations

This map shows the geographic impact of Sara Salerno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Salerno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Salerno more than expected).

Fields of papers citing papers by Sara Salerno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Salerno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Salerno. The network helps show where Sara Salerno may publish in the future.

Co-authorship network of co-authors of Sara Salerno

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Salerno. A scholar is included among the top collaborators of Sara Salerno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Salerno. Sara Salerno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Salerno, Sara, Edmund V. Capparelli, Helen McIlleron, et al.. (2022). Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(7). 638–649. 7 indexed citations

Salerno, Sara, Rong Deng, & Tarundeep Kakkar. (2022). Physiologically‐based pharmacokinetic modeling of immunoglobulin and antibody coadministration in patients with primary human immunodeficiency. CPT Pharmacometrics & Systems Pharmacology. 11(10). 1316–1327. 6 indexed citations

Salerno, Sara, et al.. (2021). Leveraging Physiologically Based Pharmacokinetic Modeling and Experimental Data to Guide Dosing Modification of CYP3A-Mediated Drug-Drug Interactions in the Pediatric Population. Drug Metabolism and Disposition. 49(9). 844–855. 9 indexed citations

Salerno, Sara, Yuting Liao, Wesley Jackson, et al.. (2020). Association between Nephrotoxic Drug Combinations and Acute Kidney Injury in the Neonatal Intensive Care Unit. The Journal of Pediatrics. 228(3). 213–219. 38 indexed citations

Salerno, Sara, Andrea N. Edginton, Matthew M. Laughon, et al.. (2020). Physiologically‐Based Pharmacokinetic Modeling Characterizes the CYP3A‐Mediated Drug‐Drug Interaction Between Fluconazole and Sildenafil in Infants. Clinical Pharmacology & Therapeutics. 109(1). 253–262. 31 indexed citations

Watt, Kevin, Andrea N. Edginton, Kelly C. Wade, et al.. (2019). Physiologically‐Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term Infants. CPT Pharmacometrics & Systems Pharmacology. 8(7). 500–510. 14 indexed citations

Salerno, Sara, Gilbert J. Burckart, Shiew‐Mei Huang, & Daniel González. (2018). Pediatric Drug–Drug Interaction Studies: Barriers and Opportunities. Clinical Pharmacology & Therapeutics. 105(5). 1067–1070. 30 indexed citations

Salerno, Sara, et al.. (2017). Pharmacokinetics of Ceftaroline in a Preterm Infant With Methicillin-Resistant Staphylococcus Aureus Pneumonia. Journal of the Pediatric Infectious Diseases Society. 7(4). 342–345. 7 indexed citations

Salerno, Sara, Christoph P. Hornik, Michael Cohen‐Wolkowiez, et al.. (2017). Use of Population Pharmacokinetics and Electronic Health Records to Assess Piperacillin–Tazobactam Safety in Infants. The Pediatric Infectious Disease Journal. 36(9). 855–859. 12 indexed citations

10.

Salerno, Sara, Andrea N. Edginton, Michael Cohen‐Wolkowiez, et al.. (2017). Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid. CPT Pharmacometrics & Systems Pharmacology. 6(12). 814–822. 11 indexed citations

11.

Thakkar, Nilay, Sara Salerno, Christoph P. Hornik, & Daniel González. (2016). Clinical Pharmacology Studies in Critically Ill Children. Pharmaceutical Research. 34(1). 7–24. 45 indexed citations

12.

Smith, Catherine C., Elisabeth A. Lasater, Xiaotian Zhu, et al.. (2013). Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD. Blood. 121(16). 3165–3171. 101 indexed citations

13.

Smith, Catherine C., Qi Wang, Chen-Shan Chin, et al.. (2012). Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia. Nature. 485(7397). 260–263. 542 indexed citations breakdown →

14.

Smith, Catherine C., Elisabeth A. Lasater, Amy L. Paguirigan, et al.. (2012). Constitutively Activating Mutations At the FLT3 Activation Loop Residue D835 Are Associated with Clinical Resistance to AC220. Blood. 120(21). 674–674. 4 indexed citations

15.

Smith, Catherine C., Lauren E. Damon, Xiaotian Zhu, Sara Salerno, & Neil P. Shah. (2011). Analysis of in Vitro Activity of the Clinically-Active ABL/FLT3 Inhibitor Ponatinib (AP24534) Against AC220-Resistant FLT3-ITD Mutants. Blood. 118(21). 930–930. 1 indexed citations

16.

Smith, Catherine C., Lauren E. Damon, Sara Salerno, & Neil P. Shah. (2011). Abstract 4737: Saturation mutagenesis of FLT3-ITD: AC220-resistance-conferring kinase domain mutations are restricted to a limited number of residues and are cross-resistant to sorafenib in vitro. Cancer Research. 71(8_Supplement). 4737–4737. 1 indexed citations

17.

Smith, Catherine C., Qi Wang, Sara Salerno, et al.. (2011). Validation of FLT3-ITD As a Therapeutic Target in Human Acute Myeloid Leukemia. Blood. 118(21). 937–937. 4 indexed citations

18.

Fiskus, Warren, Catherine C. Smith, Jacqueline Smith, et al.. (2011). Activity of Allosteric, Switch-Pocket, ABL/FLT3 Kinase Inhibitor DCC2036 Against Cultured and Primary AML Progenitors with FLT-ITD or FLT3 Kinase Domain Mutations. Blood. 118(21). 2611–2611. 3 indexed citations

19.

Wodicka, Lisa, Pietro Ciceri, Mindy I. Davis, et al.. (2010). Activation State-Dependent Binding of Small Molecule Kinase Inhibitors: Structural Insights from Biochemistry. Chemistry & Biology. 17(11). 1241–1249. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact